SCHEMBL8146384

SCHEMBL8146384

CC(C)(C)c1cc2c(c(C(C)(C)C)c1)OCCC2=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 1/20 0.38
GABBR1 Q9UBS5 1/20 0.38
PTGS1 P23219 3/20 0.36
PTGS2 P35354 3/20 0.36
ALOX5 P09917 2/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
HSP90AA1 P07900 1/20 0.32
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PLA2G1B P04054 1/20 0.31
NFKB1 P19838 1/20 0.31
CASP3 P42574 1/20 0.31
RAB9A P51151 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13468674 0.84 PTGS1 (0.38) PTGS1PTGS2ALOX5MAOAMAOB
SCHEMBL27744598 0.83 GABBR2 (0.40) GABBR2GABBR1PTGS1PTGS2HSP90AA1
SCHEMBL16259558 0.80 PTGS1 (0.34) PTGS1PTGS2ALOX5MAOAMAOB
SCHEMBL8155049 0.78 PTGS1 (0.38) GABBR2GABBR1PTGS1PTGS2ALOX5
SCHEMBL8155046 0.78 PTGS1 (0.38) GABBR2GABBR1PTGS1PTGS2ALOX5
SCHEMBL14452703 0.75 GABBR2 (0.37) GABBR2GABBR1HSP90AA1ALDH1A1
SCHEMBL431431 0.75 ALOX5 (0.36) PTGS1PTGS2ALOX5MAOAMAOB
SCHEMBL14497176 0.75 GABBR2 (0.39) GABBR2GABBR1PTGS1PTGS2ALOX5
SCHEMBL15001381 0.75 PTGS1 (0.36) PTGS1PTGS2ALOX5
SCHEMBL8153476 0.74 ALOX5 (0.34) PTGS1PTGS2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083977-A HAVING ACTIVITY FOR RETINOIC ACID RECEPTORS AND RETINOID X RECEPTORS LIGAND PHARMACEUTICALS INCORPORATED (US) 2000-07-04 US disclosed
EP-0800503-B1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARM INC (US) 2000-05-10 EP disclosed
US-5721103-A SKIN DISORDERS; VISION DEFECTS LIGAND PHARMACEUTICALS INCORPORATED (US) 1998-02-24 US disclosed
EP-0800503-A1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS, INC. (US) 1997-10-15 EP disclosed
WO-1996020913-A1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 1996-07-11 WO disclosed